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CASE  REPORT
Introduction
Neurogenic tumors may arise from peripheral nerves
or nerve sheaths, or from sympathetic ganglions. In
varying proportions, neurogenic tumors may also be
malignant. These tumors are variously termed
malignant schwannoma, neurogenic sarcoma, or
neurofibrosarcoma, but malignant peripheral nerve
sheath tumor (MPNST) is the preferred designation.
The majority of MPNSTs1,2 are derived from
neurofibroma or arise de novo in normal peripheral
nerves. Large and medium-sized nerves are more often
involved than small nerves. Schwannoma is the most
common nerve sheath tumor in the posterior
mediastinum, whereas intrathoracic paraspinal MPNST
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is quite rare. Both clinical symptoms and radiographic
images are not sufficiently reliable for diagnosis of
MPNST. Surgical resection is the main modality of
treatment. Herein, we present an unusual case of
intrathoracic paraspinal MPNST in a 50-year-old female
and review the literature.
Case Report
The patient, a 50-year-old female, had complained of
back pain for about 2 years. No neurologic symptoms,
including paresthesia or motor weakness over lower
limbs, were found. Initially, she took medication for
relief of symptoms without any roentgenographic
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examination. Physical examination revealed mild local
tenderness over the back of the chest. No skin lesions
could be identified. The chest radiographs (Figure 1)
showed a well-defined mass over the left posterior
mediastinum. Computed tomography (CT) of the
chest (Figure 2) revealed a heterogeneous parathoracic
spinal mass, from T7 through T9, which was
characterized by a large size (7 cm) chest wall invasion
and destruction of ribs and T8 pedicle. No calcification
or mediastinal lymph node enlargement could be
identified. Magnetic resonance imaging (MRI) (Figure
2) also showed compression and displacement of the
spinal cord by the posterior-lateral epidural mass. The
mass manifested heterogeneous isointensity on T1-
weighted images (T1-WI), heterogeneous high-signal
intensity on T2-WI, and heterogeneous strong contrast
enhancement. The initial impression was neurogenic
tumor with chest wall and rib invasion.
The patient underwent surgical intervention with
laminectomy of T8 and tumor resection over the
Figure 1. The chest radiographs revealed a sharply marginated
round mass over the left lower chest field. (A) PA view. (B) Lateral
view.
Figure 2. (A) The chest CT imaging revealed a big heterogeneous
paraspinal mass, with rib, T-spine vertebral body destruction, and
chest wall invasion. (B) On MRI T1-WI imaging, the mass manifested
heterogeneous postcontrast enhancement and compression and
displacement of spinal cord (arrow). V = vertebral body; T = tumor.
A
B
A
B
Malignant peripheral nerve sheath tumor in posterior mediastinum
J Chin Med Assoc • January 2006 • Vol 69 • No 1 39
parathoracic vertebral area. Microscopically, the tumor
showed fasciculated growth of tightly packed,
hyperchromatic spindle cells. The fibrosarcoma-like
fascicles were focally alternating with hypocellular
myxoid zones creating a marbleized appearance (Figure
3). Focal subtle nuclear palisading and waving nuclei
were present. Moderate cellular atypism, high mitotic
activity (18/10 HPF) (Figure 3), and foci of necrosis
were also noted. In the immunohistochemical studies,
the tumor cells were positive for S-100 stain, and
negative for cytokeratin, desmin, and CD34 stains.
Positive p53 immunoreactivity was noted in 10% of
tumor cells. The pathologic diagnosis was MPNST.
No postoperative complication was found. Adjuvant
radiation therapy was applied because of resection of
the tumor. The follow-up chest CT 5 months later
revealed residual soft tissue mass with significant
reduction in size over the parathoracic spine area.
Close follow-up was recommended.
Discussion
Neurogenic tumors account for about 10–20% of
primary mediastinal masses in adults and 30–50% in
children. They are almost exclusively located in the
posterior mediastinum.3 The tumors may arise from
peripheral nerves or nerve sheaths, including
neurofibroma, neurilemoma (schwannoma), and
malignant nerve sheath tumors (neurogenic sarcoma)
or from sympathetic ganglions, such as ganglioneuroma,
ganglioneuroblastoma, or neuroblastoma. Nearly 85%
of tumors in children are ganglion in origin,4 while, in
adults, more than 75% are nerve sheath tumors.
Schwannoma is the most common nerve sheath tumor
in the posterior mediastinum, and the vast majority arise
from one of the intercostal nerves. It may also be seen
rarely in the middle or anterior mediastinum, occurring
in relation to the vagus, phrenic, or recurrent laryngeal
nerves. Most cases are presented as a single nodule;
however, multiple schwannomas are often associated
with von Recklinghausen disease.
Clinically, peripheral nerve sheath tumors usually
do not cause symptoms and are discovered on a
screening chest roentgenogram.5 In a minority of
patients, compression of intercostal nerves or major
airways gives rise to pain or dyspnea. On plain
radiographs, nerve sheath tumors typically appear as
sharply marginated round, elliptical, or lobulated
paraspinal masses. Erosion of the ribs and vertebral
bodies sometimes is evident. On CT scan, schwannoma
has been shown to have a mixed attenuation,
attributable to a confluent area of hypocellularity
adjacent to dense cellularity, or xanthomatous change,
or regions of cystic degeneration.6 Variable
enhancement of the tumor may be seen following
contrast infusion. Calcification (about 5–10%) may be
present with either benign or malignant tumors,7 but
is not a reliable sign of benignancy. On MRI, nerve
sheath tumors typically have slightly greater signal
intensity than muscle on T1-WI and markedly increased
signal intensity on T2-WI or contrast-enhanced images,
although often in an inhomogeneous fashion. The
overall sensitivity and specificity of CT as well as MRI
in the detection of mediastinal lymph node metastasis
are 70–90% and 60–90%, respectively.8 Surgical
in te rvent ions ,  such  a s  med ia s t inoscopy ,
mediastinotomy, video-assisted thoracoscopic surgery
(VATS) or thoracotomy remain the gold standard for
a definite diagnosis.
Figure 3. (A) Microscopically, the tumor showed densely cellular fascicles alternating with hypocellular zone (right side) and subtle
nuclears palisading (arrow) were seen (hematoxylin and eosin, = 150). (B) Frequent mitoses (arrows) were present (hematoxylin and
eosin, = 400).
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Most nerve sheath tumors are encapsulated, roughly
spherical masses in gross examination. Histologically,
schwannomas are composed of spindle cells densely
packed together (Antoni A pattern) or organized
more loosely in association with a myxoid sarcoma
(Antoni B pattern); areas of infarction are common.
S-100 usually can be demonstrated in the
immunohistochemical stain. Provided complete
surgical excision can be achieved, the prognosis of
benign peripheral nerve tumors of the mediastinum is
excellent. Malignant transformation is almost
nonexistent, and the patients can be observed clinically
even when the tumor is incompletely removed because
of its location, such as nerve roots.
In varying proportions, neurogenic tumors may
also be malignant. The malignant nerve sheath tumors
are confined to the cells intrinsic to the peripheral
nerve sheath, including the perineurium and
endoneurium. They are generally regarded as being of
Schwann cell origin9 in that most of them usually
exhibit some evidence of Schwann cell differentiation
and the small minority have the features of fibroblast
or perineurial cells. These tumors are variously termed
malignant schwannoma, neurogenic sarcoma, or
neurofibrosarcoma, but malignant peripheral nerve
sheath tumor (MPNST) is the preferred designation.
The majority of MPNSTs1,2 are derived from
neurofibroma or arise de novo in normal peripheral
nerves. There were only very rare cases arising in
malignant transformation of benign schwannoma10 or
sympathetic ganglion tumors.11 Large and medium-
sized nerves are more often involved than small nerves.
Common sites of origin include the sciatic nerve,
brachial plexus, and upper arm. MPNSTs of cranial
and visceral nerves are uncommon. It is also rare in the
mediastinum. Kourea et al12 have reviewed their 35
years of data at a cancer center in New York; only 7
intrathoracic MPNSTs were identified.
Clinically, MPNSTs affect young to middle-aged
adults, with a slight female predominance.
Neurofibromatosis type 1 (NF1) predisposes to the
development of MPNSTs. About 50–60% of MPNSTs
occur in patients with NF1.1,2,12 In addition to hereditary
factors, exposure to ionizing radiation may also play a
role in the development of MPNSTs.13 MPNSTs are
usually larger and cause symptoms due to invasion of
intrathoracic organs and the thoracic wall at the time
of diagnosis. Because the symptoms may be presented
in both benign and malignant lesions, it renders
clinical differentiation of limited utility. On imaging,
MPNSTs tend to be large, infiltrating, irregular in
contour, and inhomogeneous in attenuation, although
these findings are not sufficiently reliable for diagnosis.
Histologically, MPNSTs are usually more hypercellular
with spindle cell proliferation. The tumor cells often
show hyperchromatic nuclei and are mitotically active.14
Although malignant neoplasms are usually
aggressive, surgical resection is the mainstay of therapy
for MPNST. Wide en bloc resection is the treatment
of choice for tumors involving soft tissue.2 Local
recurrence rate varied from 40% to 68%.1,2,12
Postoperative radiation therapy of MPNST has led to
a significant reduction of local recurrence.15 To date,
no chemotherapeutic regimen has proved effective in
the treatment of MPNSTs. Neoadjuvant therapy is
rarely applied in that it is not easy to differentiate
benign from malignant neurogenic tumors by imaging
preoperatively.
The prognosis of patients with MPNST is
unfavorable. In 2 major studies with long-term
follow-up, reported overall 5-year survival rates were
34–52%.1,2 The factors that appear to affect the
prognosis of patients with MPNST are tumor location,
size, histologic subtype, tumor grade, molecular
genetics, completeness of resection, recurrence,
metastasis, and presence of NF1.
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